Hemostatic and hematological abnormalities in gain-of-function fps/fes transgenic mice are associated with the angiogenic phenotype

Keyphrases

• Transgenic Mice 100%
• Angiogenic 100%
• Hemangioma 100%
• Gain-of-function 100%
• Hematological Abnormalities 100%
• Hemostatic Abnormalities 100%
• Flow Cytometry 50%
• Tyrosine Kinase 50%
• Transmission Electron Microscopy 50%
• Histology 50%
• Transgenic 50%
• Gain-of-function mutation 50%
• Platelet Aggregation 50%
• Angiogenesis 50%
• Morphological Analysis 50%
• HyPer 50%
• Inflammation 50%
• Prothrombin Time 50%
• Activated Partial Thromboplastin Time (aPTT) 50%
• Vascular Endothelium 50%
• Endothelium 50%
• Thrombin 50%
• Fibrinolysis 50%
• Hemostasis 50%
• Anemia 50%
• Platelet Function 50%
• Flow Measurement 50%
• Blood Cells 50%
• Thrombocytopenia 50%
• Clot 50%
• Hematological Parameters 50%
• Hematopoiesis 50%
• Regulatory Effect 50%
• Bleeding Diathesis 50%
• Through Effect 50%
• Hematopoietic Lineage 50%
• Hematology Analyzer 50%
• Bleeding Time 50%
• Angiogenic Function 50%
• Disseminated Intravascular Coagulation 50%
• Hemostatic Function 50%
• Haemostatic Defects 50%
• Parameter Function 50%
• Hypofibrinogenemia 50%
• Blood Transmission 50%
• Hemostatic Disorders 50%
• Hematological Traits 50%
• Peripheral Blood Smear Analysis 50%
• Kasabach-Merritt 50%
• Hypervascularity 50%
• Red Cell Abnormalities 50%
• Hemostasis Parameters 50%
• Associated Pathologies 50%
• Whole Blood Aggregometry 50%

Medicine and Dentistry

• Hemostat 100%
• Transgenic Mouse 100%
• Blood Stasis 50%
• Hemangioma 50%
• In Vitro 25%
• Allele 25%
• Phosphotransferase 25%
• Morphology 25%
• Angiogenesis 25%
• Flow Cytometry 25%
• Vascular Endothelium 25%
• Fibrinolysis 25%
• Anemia 25%
• Thrombocyte Aggregation 25%
• Thrombocyte Function 25%
• Thrombocytopenia 25%
• Partial Thromboplastin Time 25%
• Coagulopathy 25%
• Transmission Electron Microscopy 25%
• Hematopoiesis 25%
• Prothrombin Time 25%
• Thrombin 25%
• Disseminated Intravascular Coagulation 25%
• Bleeding Diathesis 25%
• Bleeding Time 25%
• Hypervascularity 25%
• Protein Kinase Fes 25%
• Kasabach-Merritt Syndrome 25%
• Hypofibrinogenemia 25%
• Blood Analysis 25%
• Flow Measurement 25%